Human Parvovirus and giant cell arteritis: A selective arteritic impact?

Clinical and Experimental Rheumatology

Volumn 18, Issue SUPPL. 20, 2000, Pages

  Elling, H ^a   Olsson, A T ^a   Elling, P ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

Epidemics; Giant cell arteritis; Parvovirus

Indexed keywords

IMMUNOGLOBULIN M;

CONFERENCE PAPER; DENMARK; EPIDEMIC; GIANT CELL ARTERITIS; HUMAN; INCIDENCE; PARVOVIRUS; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SEROEPIDEMIOLOGY; TEMPORAL ARTERITIS;

ANTIBODIES, VIRAL; DENMARK; DISEASE OUTBREAKS; HUMANS; INCIDENCE; MYCOPLASMA PNEUMONIAE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; PNEUMONIA, MYCOPLASMA; SEROEPIDEMIOLOGIC STUDIES; TEMPORAL ARTERITIS;

EID: 0033839234     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern
2. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection
3. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)
4. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent?
5. Wegener's granulomatosis and parvovirus B19 infection
6. Association of parvovirus B19 infection with giant cell arteritis
7. Parvovirus B19 encephalopathy